Surrey researchers Sign in
Formoterol, a Highly beta(2)-Selective Agonist, Induces Gender-Dimorphic Whole Body Leucine Metabolism in Humans
Journal article

Formoterol, a Highly beta(2)-Selective Agonist, Induces Gender-Dimorphic Whole Body Leucine Metabolism in Humans

P Lee, V Birzniece, AM Umpleby, A Poljak and KKY Ho
METABOLISM-CLINICAL AND EXPERIMENTAL, Vol.64(4), pp.506-512
01/04/2015

Abstract

Science & Technology Life Sciences & Biomedicine Endocrinology & Metabolism Beta-agonist Formoterol Skeletal muscle Leucine turnover Sarcopenia GROWTH-HORMONE SKELETAL-MUSCLE THERAPEUTIC IMPLICATIONS PROTEIN-METABOLISM ENERGY-METABOLISM CUSHINGS-SYNDROME AMINO-ACIDS SARCOPENIA MEN FRAILTY
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000350613000006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Details

Usage Policy